# A Safety and Pharmacokinetics Study of ZB004 in Healthy Participants

> **NCT05794516** · PHASE1 · COMPLETED · sponsor: **Zenas BioPharma (USA), LLC** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ZB004
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05794516
- **Lead sponsor:** Zenas BioPharma (USA), LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-19
- **Primary completion:** 2024-03-21
- **Final completion:** 2024-03-21
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05794516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05794516, "A Safety and Pharmacokinetics Study of ZB004 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05794516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*